» Articles » PMID: 26945731

Long-term Exposure to ELF-MF Ameliorates Cognitive Deficits and Attenuates Tau Hyperphosphorylation in 3xTg AD Mice

Overview
Journal Neurotoxicology
Date 2016 Mar 7
PMID 26945731
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Although numerous studies have reported the influence of extremely low frequency magnetic field (ELF-MF) exposure on human health, its effects on cognitive deficits in Alzheimer's disease (AD) have remained under debate. Moreover, the influence of ELF-MF on hyperphosphorylated tau, which is one of the most common pathological hallmarks of AD, has not been reported to date. Therefore, transgenic mice (3xTg) were used in the present study. 3xTg mice, which express an APP/PS1 mutation combined with a tau (P301L) mutation and that develop cognitive deficits at 6 months of age, were subjected to ELF-MF (50Hz, 500μT) exposure or sham exposure daily for 3 months. We discovered that ELF-MF exposure ameliorated cognitive deficits and increased synaptic proteins in 3xTg mice. The protective effects of ELF-MF exposure may have also been caused by the inhibition of apoptosis and/or decreased oxidative stress levels that were observed in the hippocampus tissues of treated mice. Furthermore, tau hyperphosphorylation was decreased in vivo because of ELF-MF exposure, and this decrease was induced by the inhibition of GSK3β and CDK5 activities and activation of PP2Ac. We are the first to report that exposure to ELF-MF can attenuate tau phosphorylation. These findings suggest that ELF-MF exposure could act as a valid therapeutic strategy for ameliorating cognitive deficits and attenuating tau hyperphosphorylation in AD.

Citing Articles

Examining the effects of extremely low-frequency magnetic fields on cognitive functions and functional brain markers in aged mice.

Hadzibegovic S, Nicole O, Andelkovic V, de Gannes F, Hurtier A, Lagroye I Sci Rep. 2025; 15(1):8365.

PMID: 40069380 PMC: 11897315. DOI: 10.1038/s41598-025-93230-y.


Neurobiological effects and mechanisms of magnetic fields: a review from 2000 to 2023.

Wang X, Ye Y, Zuo H, Li Y BMC Public Health. 2024; 24(1):3094.

PMID: 39516768 PMC: 11545338. DOI: 10.1186/s12889-024-18987-9.


Electromagnetic Field Stimulation Therapy for Alzheimer's Disease.

Perez F, Morisaki J, Kanakri H, Rizkalla M Neurology (Chic). 2024; 3(1).

PMID: 38699565 PMC: 11064876.


Use of Fast Gamma Magnetic Stimulation Over the Left Prefrontal Dorsolateral Cortex for the Treatment of MCI and Mild Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled, Pilot Study.

Mimenza-Alvarado A, Aguilar-Navarro S, Martinez-Carrillo F, Rios-Ponce A, Villafuerte G Front Neurol. 2021; 12:729872.

PMID: 34566873 PMC: 8458744. DOI: 10.3389/fneur.2021.729872.


Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures.

Perez F, Maloney B, Chopra N, Morisaki J, Lahiri D Sci Rep. 2021; 11(1):621.

PMID: 33436686 PMC: 7804462. DOI: 10.1038/s41598-020-77808-2.